Modern possibilities of drug treatment of atherosclerosis: the use of drugs with angioprotective, antithrombotic and immunomodulatory effects
- Authors: Ibragimov O.B.1,2, Bogoyavlenskiy V.F.1,2, Kamburg R.A.1,2, Garaev R.S.1,2
-
Affiliations:
- Kazan Institute for Postgraduate Medical Education
- Kazan Medical University
- Issue: Vol 75, No 6 (1994)
- Pages: 453-461
- Section: Reviews
- URL: https://journals.rcsi.science/kazanmedj/article/view/100119
- DOI: https://doi.org/10.17816/kazmj100119
- ID: 100119
Cite item
Full Text
Abstract
To date, it can be considered an established fact that modern anti-atherosclerotic therapy can affect the anatomical severity of atherosclerosis. In the treatment of atherosclerosis, two main approaches are used: treatment aimed at regression of an already existing disease, and treatment with the aim of delaying its development in individuals predisposed to it. Hyperlipidemia is generally recognized as the most significant risk factor and marker for the prevalence of atherosclerosis [9, 22, 26]. The results of the six largest studies on primary and secondary prevention of atherosclerosis in individuals with hyperlipidemia show that both approaches reduce morbidity and mortality from coronary artery disease (Table 1).
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
O. B. Ibragimov
Kazan Institute for Postgraduate Medical Education; Kazan Medical University
Author for correspondence.
Email: info@eco-vector.com
Department of Therapy No. 2, Department of Pharmacology, Central Research Laboratory
Russian Federation, Kazan; KazanV. F. Bogoyavlenskiy
Kazan Institute for Postgraduate Medical Education; Kazan Medical University
Email: info@eco-vector.com
Department of Therapy No. 2, Department of Pharmacology, Central Research Laboratory
Russian Federation, Kazan; KazanR. A. Kamburg
Kazan Institute for Postgraduate Medical Education; Kazan Medical University
Email: info@eco-vector.com
Department of Therapy No. 2, Department of Pharmacology, Central Research Laboratory
Russian Federation, Kazan; KazanR. S. Garaev
Kazan Institute for Postgraduate Medical Education; Kazan Medical University
Email: info@eco-vector.com
Department of Therapy No. 2, Department of Pharmacology, Central Research Laboratory
Russian Federation, Kazan; KazanReferences
Supplementary files
